Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9404480 | Surgery | 2005 | 8 Pages |
Abstract
The proteolytic activation of pro-MMP-9 in skin inflammatory diseases likely occurs via a pathway including IL-1α. The activation is mediated by downregulation of tissue inhibitor of MMP-1 and involves an as yet unidentified chymotrypsinlike proteinase.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Yuan-Ping PhD, Susan MD, Warren L. MD,